Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00918567Phase 4Completed
A Phase 4 trial of atomoxetine in attention deficit hyperactivity disorder (ADHD), sponsored by University at Buffalo. Started Jan 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00918567.